MichBio Hiring: Intern, Association Membership & Resource Analytics

April 15, 2025

MichBio seeks a highly motivated individual who can work creatively in a small team environment and assist in data mining, compilation, and research.

MichBio seeks a highly motivated individual who can work creatively in a small team environment and assist in data mining, compilation, and research. 

 

MichBio is the non-profit trade association devoted to serving and being the voice of the biosciences industry in Michigan. The organization’s mission is to drive bio-industry growth through education and resources, business connectivity and promotion, and advocacy and policy engagement. Ultimately, our goal is to grow MichBio’s brand, attract new members, connect the ecosystem, and promote healthy relations with our business partners. 

 

POSITION: 

Intern, Association Membership & Resource Analytics 

 

JOB DESCRIPTION: 

As an Intern, Association Membership & Resource Analytics you will will focus on researching and analyzing data critical to our membership and impact functions including curating our organization database and association management system. 

 

RESPONSIBILITIES: 

  • Help review, organize, curate, and annotate membership and organization database ensuring data accuracy and integrity. 
  • Assist in identifying ways to better track organizational activities and impacts while enhancing our data management processes. 
  • Collaborate with team members to understand data needs and usage across different projects and initiatives. 
  • Help implement mechanisms for regular data gathering, maintenance, and quality checks to ensure database reliability. 
  • Assist in the evaluation of potential new CRM systems, platforms or enhancements to better meet organizational needs. 
  • Participate in the development of data management standard operating procedures to ensure best practices in data handling and privacy. 

 

QUALIFICATIONS: 

  • Currently enrolled in or recently graduated from a degree program/specialization in Data Management, Analytics, or a related field like Association Management. 
  • Proficiency, or at least familiarity, in Customer Relationship Management (CRM) or Association Management System (AMS) software (e.g., Salesforce or others) is highly desirable. 
  • Strong research skills and ability to use online search and data capture tools. 
  • Keen interest in learning and mastering new technologies. 
  • Strong Excel spreadsheet skills. 
  • Excellent analytical and problem-solving skills, with meticulous attention to detail. 
  • Prior experience with data management, analysis, or related areas is a plus. 

 

SOFT SKILLS REQUIRED: 

  • Hardworking, entrepreneurial spirit who takes initiative and can work independently when needed. 
  • Acute attention to detail. 
  • Effective communication and interpersonal skills with a willingness to secure data and information from end users. 
  • Ability to work collaboratively within a small team to accomplish project goals. 
  • Desire to be part of a mission-driven organization and contribute to its growth and reputation. 

 

COMPENSATION: 

The internship will be a full-time role (40 hours per week) at $18/hour for a duration of 13-20 weeks depending on an individual’s educational calendar commitments. 

 

WORK ENVIRONMENT/LOCATION: 

On-site flexible – work/life balance-friendly - can be fully onsite or hybrid position with in-person office days required. 


Position Open to MICHIGAN RESIDENTS and STUDENTS ONLY.

 

Send cover letter and resume with three references with “Data Management Intern: MichBio” in the subject line to: stephen@michbio.org

RECENT ARTICLES

April 24, 2025
Prenuptial Patenting: Responsible Engagement with Engineering Firms
April 24, 2025
PharmOptima, a Poratge, Michigan-based preclinical contract research organization (CRO) is advancing drug discovery through its comprehensive suite of services. Specializing in in-vivo ADME/PK, ocular research, as well as regulated large and small molecule bioanalytical and ligand binding services, PharmOptima supports clients in optimizing drug development programs efficiently and effectively. With a staff averaging 11 years of industry experience and multiple individuals with advanced degrees, PharmOptima also boasts one of the most capable and engaging teams in the industry. The company collaborates with board-certified veterinary ophthalmologist Dr. Ryan Boyd, further enhancing its ocular research capabilities. PharmOptima's team of experts is dedicated to providing high-quality services to the pharmaceutical biotechnology industries. Looking ahead, PharmOptima scientists will be presenting posters at the 2025 The Association for Research in Vision and Ophthalmology (ARVO) conference, showcasing their latest research and innovations in ocular drug development. For more information visit www.pharmoptima.com .
April 24, 2025
Two bills, HB 4332 and HB 4333 were recently re-introduced that would prohibit pathogen gain-of-function (GoF) research. Given that the House is now Republican-led raises concerns for MichBio and others that the legislation might gain traction due to misinformation over biosafety and pandemic origins. MichBio opposes such broad legislative bans as they risk undermining critical scientific progress, public health preparedness, and economic innovation. GoF research has been instrumental in developing life-saving therapies and vaccines. For instance, viral vector-based gene therapies, such as Sarepta's Elevidys for Duchenne muscular dystrophy, and oncolytic virotherapies like Amgen's Imlygic for melanoma, rely on genetically modified viruses to deliver therapeutic genes or selectively destroy cancer cells. These advancements stem from GoF methodologies that enhance viral capabilities for therapeutic purposes. Moreover, GoF research has played a pivotal role in vaccine development. Examples like the AstraZeneca and Janssen COVID-19 vaccines and Merck's ERVEBO vaccine against Ebola employs a genetically modified virus to confer protection, underscore the public health benefits derived from GoF studies. ​ Contrary to concerns that GoF research operates without sufficient oversight, multiple layers of regulation are in place. Since 2017, the U.S. Department of Health and Human Services has implemented a framework to evaluate and guide funding decisions for GoF research, particularly those involving potential pandemic pathogens. This framework includes stringent safety protocols, risk assessments, and ethical reviews. ​ MichBio is most concerned that any legislative bans that broadly define and prohibit GoF research risk stifling innovation across various scientific fields. Such bans could inadvertently encompass research in virology, microbiology, molecular biology, and synthetic biology—disciplines vital for developing new therapies, sustainable agricultural practices, and environmental remediation technologies. ​ In turn, state-level bans on GoF research could have detrimental effects on local economies and academic institutions. Such a ban could impede research critical to understanding and combating diseases, leading to a loss of federal and philanthropic funding. This could hamper the growth of the Michigan's biotech and biomedical sectors. ​  MichBio advocates for a balanced approach that reinforces existing oversight mechanisms and fosters transparent, responsible research practices essential to safeguard both public health and scientific progress.